Presentation,
22nd annual San Antonio Breast Cancer Symposium
(Source: Breast Cancer Update for Surgeons, Program 1 2000)
Play
Audio Below:
The
first thing you want to do is make a thorough assessment of their
level of risk using known breast cancer risk factors. And because
there has been a lot of controversy in the literature about the
ability of pathologists to diagnose atypical hyperplasia, we know
that if they use a standard set of criteria, they will reproducibly
make this diagnosis by and large, or at least in 77 percent of cases.
If you don’t see a lot of benign breast pathology ¾ if
you have uncertainties ¾ a second opinion is a useful thing.
Secondly, as you would with any high-risk woman, you need to find
out what is concerning her. Is it fear of breast cancer death? Is
it fear of surgery? How does this impact upon quality of life?
Chemoprevention
of breast cancer [Review]. Brown, P. H. and Lippman, S. M. (Reprint available from: Lippman
SM Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Prevent 1515
Holcombe Blvd,Box 236 Houston, TX 77030 USA). Breast Cancer Research
& Treatment. 62(1):1-17, 2000 Jul.
Vitamin
A analogue for breast cancer prevention: a grade of F or incomplete?
Response Piantadosi, S. (Reprint available from: Piantadosi S Johns Hopkins
Univ, Sch Med, Johns Hopkins Oncol Ctr 550 N Broadway,Suite 1103
Baltimore, MD 21205 USA).. Journal of the National Cancer Institute.
92(3):274-275, 2000 Feb 2. No abstract
Tamoxifen
for the prevention of breast cancer in the high-risk woman.
Morrow, M. and Jordan, V. C. (Reprint available from: Morrow M 676
N St Clair St,13th Floor, Room 13-104 Chicago, IL 60611 USA).. Annals
of Surgical Oncology. 7(1):67-71, 2000 Jan-Feb. No abstract
